Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Vistagen Therapeutics (NASDAQ:VTGN) Stock In Breakout: How to Trade Now?

Biopharmaceutical company Vistagen Therapeutics (NASDAQ:VTGN), engaged in new generation of medicines having potential of going beyond standard current care for nervous system disorders, has confirmed appointment of Mary L. Rotunno, J.D. to the Board of Directors. Shawn Singh, Chief Executive Officer of VistaGen, appreciated Mary’s experience of over three decades in leadership commencing with serving …